It occurs in less than 1% of patients
Isoniazid, cycloserine, penicillamine, hydralazine: These drugs act as Pyridoxine antagonists and lower B6 levels in the body
Gawne PJ, Ferreira M, Papaluca M, Grimm J, Decuzzi P
Taylor Kohn, M.D., is a fellow in male reproductive medicine and surgery at Baylor College of Medicine James Staheli, D.O., is the medical director for Broad Health and a family medicine doctor specializing in hormone treatment for men
A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptor-positive metastatic triple-negative breast cancer
All compounds are strictly intended for research use only (RUO) and are not approved for human medical or therapeutic use